Annual Income Tax
-$633.43 M
-$1.06 B-247.34%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual income tax is currently -$633.43 million, with the most recent change of -$1.06 billion (-247.34%) on 31 March 2024. During the last 3 years, it has fallen by -$539.70 million (-575.82%). TAK annual income tax is now -125.91% below its all-time high of $2.45 billion, reached on 31 March 2007.TAK Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$183.57 M
-$81.39 M-30.72%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly income tax is currently $183.57 million, with the most recent change of -$81.39 million (-30.72%) on 01 September 2024. Over the past year, it has increased by +$515.93 million (+155.23%). TAK quarterly income tax is now -76.43% below its all-time high of $778.85 million, reached on 30 June 2021.TAK Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
-$152.85 M
+$515.93 M+77.14%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited TTM income tax is currently -$152.85 million, with the most recent change of +$515.93 million (+77.14%) on 01 September 2024. Over the past year, it has dropped by -$194.94 million (-463.19%). TAK TTM income tax is now -109.64% below its all-time high of $1.59 billion, reached on 31 March 2012.TAK TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Income Tax Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -247.3% | +155.2% | -463.2% |
| 3 y3 years | -575.8% | +30.8% | -133.3% |
| 5 y5 years | -840.3% | +142.1% | +80.6% |
TAK Income Tax High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -198.2% | at low | -52.9% | +150.0% | -122.5% | +77.1% |
| 5 y | 5 years | -198.2% | +34.5% | -76.4% | +116.9% | -122.5% | +84.3% |
| alltime | all time | -125.9% | +34.5% | -76.4% | +116.9% | -109.6% | +84.3% |
Takeda Pharmaceutical Company Limited Income Tax History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $183.57 M(-30.7%) | -$152.85 M(-77.1%) |
| June 2024 | - | $264.96 M(-188.3%) | -$668.78 M(+11.2%) |
| Mar 2024 | -$633.43 M(-247.3%) | -$300.02 M(-0.4%) | -$601.23 M(+245.2%) |
| Dec 2023 | - | -$301.35 M(-9.3%) | -$174.18 M(-513.9%) |
| Sept 2023 | - | -$332.37 M(-200.0%) | $42.09 M(-89.3%) |
| June 2023 | - | $332.51 M(+161.8%) | $394.84 M(-12.6%) |
| Mar 2023 | $429.91 M(-33.3%) | $127.03 M(-249.3%) | $451.70 M(-1159.2%) |
| Dec 2022 | - | -$85.09 M(-517.3%) | -$42.64 M(-125.3%) |
| Sept 2022 | - | $20.39 M(-94.8%) | $168.88 M(-41.5%) |
| June 2022 | - | $389.37 M(-206.0%) | $288.88 M(-57.4%) |
| Mar 2022 | $644.96 M(-788.1%) | -$367.31 M(-390.5%) | $678.36 M(+61.5%) |
| Dec 2021 | - | $126.44 M(-9.9%) | $419.99 M(-8.6%) |
| Sept 2021 | - | $140.39 M(-82.0%) | $459.76 M(+94.4%) |
| June 2021 | - | $778.85 M(-224.5%) | $236.45 M(-340.1%) |
| Mar 2021 | -$93.73 M(-90.3%) | -$625.68 M(-476.5%) | -$98.46 M(-82.4%) |
| Dec 2020 | - | $166.20 M(-300.4%) | -$559.28 M(+177.2%) |
| Sept 2020 | - | -$82.92 M(-118.7%) | -$201.76 M(-63.6%) |
| June 2020 | - | $443.94 M(-140.9%) | -$554.70 M(-42.8%) |
| Mar 2020 | -$966.49 M(+1334.8%) | -$1.09 B(-307.5%) | -$970.60 M(+176.0%) |
| Dec 2019 | - | $523.72 M(-220.2%) | -$351.70 M(-55.4%) |
| Sept 2019 | - | -$435.86 M(-1654.3%) | -$789.07 M(+321.6%) |
| June 2019 | - | $28.04 M(-106.0%) | -$187.16 M(+165.5%) |
| Mar 2019 | -$67.36 M(-124.5%) | -$467.60 M(-641.5%) | -$70.50 M(-129.0%) |
| Dec 2018 | - | $86.35 M(-48.0%) | $243.00 M(+499.8%) |
| Sept 2018 | - | $166.05 M(+14.7%) | $40.52 M(-165.5%) |
| June 2018 | - | $144.71 M(-193.9%) | -$61.84 M(-122.7%) |
| Mar 2018 | $275.25 M(+6.9%) | -$154.11 M(+32.7%) | $272.76 M(-12.8%) |
| Dec 2017 | - | -$116.13 M(-282.3%) | $312.97 M(-41.3%) |
| Sept 2017 | - | $63.70 M(-86.7%) | $533.32 M(+94.0%) |
| June 2017 | - | $479.30 M(-520.8%) | $274.98 M(+8.9%) |
| Mar 2017 | $257.37 M(-16.7%) | -$113.89 M(-209.3%) | $252.45 M(-29.1%) |
| Dec 2016 | - | $104.22 M(-153.5%) | $356.08 M(+89.8%) |
| Sept 2016 | - | -$194.65 M(-142.6%) | $187.57 M(-67.0%) |
| June 2016 | - | $456.78 M(-4548.8%) | $568.50 M(+87.2%) |
| Mar 2016 | $308.83 M | -$10.27 M(-84.0%) | $303.74 M(-151.5%) |
| Dec 2015 | - | -$64.29 M(-134.5%) | -$589.28 M(+1304.3%) |
| Sept 2015 | - | $186.28 M(-3.0%) | -$41.96 M(-851.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $192.01 M(-121.3%) | $5.58 M(-91.4%) |
| Mar 2015 | -$21.97 M(-104.5%) | -$903.28 M(-287.0%) | $64.94 M(-92.3%) |
| Dec 2014 | - | $483.03 M(+106.6%) | $842.69 M(+44.3%) |
| Sept 2014 | - | $233.82 M(-7.0%) | $583.86 M(+4.9%) |
| June 2014 | - | $251.38 M(-300.2%) | $556.84 M(+11.3%) |
| Mar 2014 | $492.14 M(-330.7%) | -$125.54 M(-156.0%) | $500.32 M(+218.4%) |
| Dec 2013 | - | $224.19 M(+8.4%) | $157.13 M(+15.8%) |
| Sept 2013 | - | $206.81 M(+6.1%) | $135.64 M(-33.8%) |
| June 2013 | - | $194.85 M(-141.6%) | $204.77 M(-238.8%) |
| Mar 2013 | -$213.29 M(-113.4%) | -$468.72 M(-331.2%) | -$147.50 M(-137.5%) |
| Dec 2012 | - | $202.70 M(-26.5%) | $392.86 M(-51.1%) |
| Sept 2012 | - | $275.94 M(-275.3%) | $803.03 M(-11.4%) |
| June 2012 | - | -$157.41 M(-319.7%) | $906.49 M(-42.9%) |
| Mar 2012 | $1.59 B(+12.6%) | $71.64 M(-88.3%) | $1.59 B(+2.6%) |
| Dec 2011 | - | $612.87 M(+61.5%) | $1.55 B(+10.1%) |
| Sept 2011 | - | $379.40 M(-27.4%) | $1.40 B(-6.4%) |
| June 2011 | - | $522.45 M(+1544.1%) | $1.50 B(+7.0%) |
| Mar 2011 | $1.41 B(+13.0%) | $31.78 M(-93.3%) | $1.40 B(-3.5%) |
| Dec 2010 | - | $470.96 M(-0.8%) | $1.45 B(-1.4%) |
| Sept 2010 | - | $474.95 M(+12.1%) | $1.47 B(+3.6%) |
| June 2010 | - | $423.68 M(+410.3%) | $1.42 B(+13.9%) |
| Mar 2010 | $1.25 B(-23.2%) | $83.03 M(-83.1%) | $1.25 B(+2.5%) |
| Dec 2009 | - | $490.92 M(+15.7%) | $1.22 B(-5.5%) |
| Sept 2009 | - | $424.46 M(+69.8%) | $1.29 B(+5.3%) |
| June 2009 | - | $249.96 M(+378.3%) | $1.22 B(+25.7%) |
| Mar 2009 | $1.62 B(-15.5%) | $52.25 M(-90.7%) | $973.47 M(+5.7%) |
| Dec 2008 | - | $561.65 M(+56.2%) | $921.22 M(+156.2%) |
| Sept 2008 | - | $359.57 M | $359.57 M |
| Mar 2008 | $1.92 B(-21.5%) | - | - |
| Mar 2007 | $2.45 B(+37.3%) | - | - |
| Mar 2006 | $1.78 B(+19.3%) | - | - |
| Mar 2005 | $1.49 B(+6.6%) | - | - |
| Mar 2004 | $1.40 B(+8.3%) | - | - |
| Mar 2003 | $1.29 B(+19.7%) | - | - |
| Mar 2002 | $1.08 B(+4.5%) | - | - |
| Mar 2001 | $1.03 B(+40.8%) | - | - |
| Mar 2000 | $734.41 M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual income tax?
- What is the all time high annual income tax for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual income tax year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly income tax?
- What is the all time high quarterly income tax for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly income tax year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM income tax?
- What is the all time high TTM income tax for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM income tax year-on-year change?
What is Takeda Pharmaceutical Company Limited annual income tax?
The current annual income tax of TAK is -$633.43 M
What is the all time high annual income tax for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual income tax is $2.45 B
What is Takeda Pharmaceutical Company Limited annual income tax year-on-year change?
Over the past year, TAK annual income tax has changed by -$1.06 B (-247.34%)
What is Takeda Pharmaceutical Company Limited quarterly income tax?
The current quarterly income tax of TAK is $183.57 M
What is the all time high quarterly income tax for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly income tax is $778.85 M
What is Takeda Pharmaceutical Company Limited quarterly income tax year-on-year change?
Over the past year, TAK quarterly income tax has changed by +$515.93 M (+155.23%)
What is Takeda Pharmaceutical Company Limited TTM income tax?
The current TTM income tax of TAK is -$152.85 M
What is the all time high TTM income tax for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM income tax is $1.59 B
What is Takeda Pharmaceutical Company Limited TTM income tax year-on-year change?
Over the past year, TAK TTM income tax has changed by -$194.94 M (-463.19%)